Thomas Jones, MD
Gastroenterology · Liberty, MONPI 1740283753
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $318 of the $370 with a category attached, or 86.0%. 9 manufacturers reported payments, led by AbbVie at 35.8% of the total. That places this record below the midpoint for gastroenterology clinicians in MO, where the typical reported total is $1,415.
Across 18 payments — averaging $20.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$133
- Johnson & Johnson$69
- Takeda Pharmaceuticals U.S.A., Inc.$50
- Pfizer$33
- Celltrion USA Inc.$22
- Shionogi Inc$21
- plus $42 from 3 others
What the payments were for
- Food & beverage$31886%
- Education$5214%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 7 | $133 |
| Johnson & Johnson | 2 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Pfizer | 2 | $33 |
| Celltrion USA Inc. | 1 | $22 |
| Shionogi Inc | 1 | $21 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Merck | 1 | $13 |
How this compares
$370 in reported general payments places this provider in the 25th percentile of 374 gastroenterology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 14 | $93,366 |
| Mesalamine | 21 | $16,940 |
| Pantoprazole Sodium | 190 | $2,544 |
| Omeprazole | 120 | $2,343 |
| SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag | 17 | $2,044 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 12 | $1,948 |
| Colestipol Hcl | 23 | $1,442 |
| Sucralfate | 26 | $1,020 |
| Dicyclomine Hcl | 23 | $742 |
| Famotidine | 56 | $576 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 40 | $564 |
| Azathioprine | 11 | $424 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 22 | $319 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Liberty
- Gregory SayukSaint Louis$1.1M
- Katie SchroederSaint Louis$730K
- David AlpersSaint Louis$616K
- Kamran QureshiLake St Louis$279K
- Laith Al MomaniKansas City$249K
- Ahmed SaeedKansas City$246K
- Parakkal DeepakSaint Louis$205K
- Bradley AndersonColumbia$194K
- Mauricio Lisker MelmanSaint Louis$179K
- Matthew CiorbaSaint Louis$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.